These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

3884 related items for PubMed ID: 28099945

  • 1. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY, Xue M, Zhang QC, Su CF.
    Oncotarget; 2017 Feb 28; 8(9):15507-15519. PubMed ID: 28099945
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-27a Promotes the Proliferation and Invasiveness of Colon Cancer Cells by Targeting SFRP1 through the Wnt/β-Catenin Signaling Pathway.
    Ba S, Xuan Y, Long ZW, Chen HY, Zheng SS.
    Cell Physiol Biochem; 2017 Feb 28; 42(5):1920-1933. PubMed ID: 28772260
    [Abstract] [Full Text] [Related]

  • 3. Silencing microRNA-27a inhibits proliferation and invasion of human osteosarcoma cells through the SFRP1-dependent Wnt/β-catenin signaling pathway.
    Mu Y, Zhang L, Chen X, Chen S, Shi Y, Li J.
    Biosci Rep; 2019 Jun 28; 39(6):. PubMed ID: 31072914
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-27a-3p Modulates the Wnt/β-Catenin Signaling Pathway to Promote Epithelial-Mesenchymal Transition in Oral Squamous Carcinoma Stem Cells by Targeting SFRP1.
    Qiao B, He BX, Cai JH, Tao Q, King-Yin Lam A.
    Sci Rep; 2017 Apr 20; 7():44688. PubMed ID: 28425477
    [Abstract] [Full Text] [Related]

  • 5. MiRNA-27a promotes the proliferation and invasion of human gastric cancer MGC803 cells by targeting SFRP1 via Wnt/β-catenin signaling pathway.
    Wu F, Li J, Guo N, Wang XH, Liao YQ.
    Am J Cancer Res; 2017 Apr 20; 7(3):405-416. PubMed ID: 28401000
    [Abstract] [Full Text] [Related]

  • 6. Effects of microRNA-135a on the epithelial-mesenchymal transition, migration and invasion of bladder cancer cells by targeting GSK3β through the Wnt/β-catenin signaling pathway.
    Mao XW, Xiao JQ, Li ZY, Zheng YC, Zhang N.
    Exp Mol Med; 2018 Jan 19; 50(1):e429. PubMed ID: 29350680
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
    Mohammadi-Yeganeh S, Paryan M, Arefian E, Vasei M, Ghanbarian H, Mahdian R, Karimipoor M, Soleimani M.
    Tumour Biol; 2016 Jul 19; 37(7):8993-9000. PubMed ID: 26758430
    [Abstract] [Full Text] [Related]

  • 8. MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/β-catenin signaling pathway.
    Jiang Q, He M, Guan S, Ma M, Wu H, Yu Z, Jiang L, Wang Y, Zong X, Jin F, Wei M.
    Tumour Biol; 2016 Apr 19; 37(4):5001-11. PubMed ID: 26537584
    [Abstract] [Full Text] [Related]

  • 9. MicroRNA-744 promotes prostate cancer progression through aberrantly activating Wnt/β-catenin signaling.
    Guan H, Liu C, Fang F, Huang Y, Tao T, Ling Z, You Z, Han X, Chen S, Xu B, Chen M.
    Oncotarget; 2017 Feb 28; 8(9):14693-14707. PubMed ID: 28107193
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. MicroRNA-27a targets Sfrp1 to induce renal fibrosis in diabetic nephropathy by activating Wnt/β-Catenin signalling.
    Shi M, Tian P, Liu Z, Zhang F, Zhang Y, Qu L, Liu X, Wang Y, Zhou X, Xiao Y, Guo B.
    Biosci Rep; 2020 Jun 26; 40(6):. PubMed ID: 32484208
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 195.